Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

BACKGROUND: Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic myelopathy characterized by motor dysfunction of the lower extremities and urinary disturbance. Immunomodulatory treatments are the main strategy for HAM/TSP, but several...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tatsufumi, Matsuo, Tomohiro, Fukuda, Taku, Yamato, Shinji, Yamaguchi, Kentaro, Kinoshita, Ikuo, Matsuzaki, Toshio, Nishiura, Yoshihiro, Nagasato, Kunihiko, Narita-Masuda, Tomoko, Nakamura, Hideki, Satoh, Katsuya, Sasaki, Hitoshi, Sakai, Hideki, Kawakami, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826868/
https://www.ncbi.nlm.nih.gov/pubmed/23945290
http://dx.doi.org/10.1186/1741-7015-11-182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826868/
https://www.ncbi.nlm.nih.gov/pubmed/23945290
http://dx.doi.org/10.1186/1741-7015-11-182

Ejemplares similares